Back to Search

ROHITH VADLAMUDI, MD

MD

Internal Medicine Physician

NPI: 1619439783IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hospitalist Physician

Hospitalist

Code: 208M00000X

47239(AL)
Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

11912795-1205(UT)

CMS Specialties

PrimaryHOSPITALIST

Education

UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE

Class of 2019

Research & Publications (20)

Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR.
PMID 17525794·Nucl Recept Signal·2007
6-review
Extranuclear coactivator signaling confers insensitivity to tamoxifen.
PMID 19470742·Clin Cancer Res·2009
7-preclinical
The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
PMID 19605405·Cancer Res·2009
8-other
PELP1--a novel estrogen receptor-interacting protein.
PMID 18571832·Mol Cell Endocrinol·2008
6-review
MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation.
PMID 18682536·Am J Physiol Endocrinol Metab·2008
8-other
Role of PELP1/MNAR signaling in ovarian tumorigenesis.
PMID 18559538·Cancer Res·2008
7-preclinical
Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
PMID 18079323·Mol Endocrinol·2008
8-other
Rapid estrogen signaling in the brain.
PMID 18253054·Neurosignals·2008
6-review
Strongyloides hyperinfection syndrome complicating (ectopic) Cushing syndrome.
PMID 18580721·South Med J·2008
5-case
Nurses' attitudes, beliefs and confidence levels regarding care for those who abuse alcohol: impact of educational intervention.
PMID 18042433·Nurse Educ Pract·2008
8-other
Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway.
PMID 18505929·Mol Cancer Res·2008
7-preclinical
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
PMID 17545633·Cancer Res·2007
7-preclinical
Interaction between warfarin and levofloxacin: case series.
PMID 17639754·South Med J·2007
5-case
Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).
PMID 17505058·Mol Endocrinol·2007
7-preclinical
Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
PMID 17192406·Mol Endocrinol·2007
7-preclinical
Identifying the estrogen receptor coactivator PELP1 in autophagosomes.
PMID 17804729·Cancer Res·2007
8-other
Emerging significance of ER-coregulator PELP1/MNAR in cancer.
PMID 17128415·Histol Histopathol·2007
6-review
Intestinal strongyloidiasis and hyperinfection syndrome.
PMID 16734908·Clin Mol Allergy·2006
8-other
Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR.
PMID 16826428·Clin Exp Metastasis·2006
6-review
Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells.
PMID 16912174·Cancer Res·2006
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
619 19TH ST S, CAMILLA PAVILION ROOM P915
BIRMINGHAM, AL 35249

Locations (2)

Practice Location

619 19TH ST S, BIRMINGHAM, AL
(205) 975-0512

Practice Location

30 N 1900 E RM 4C116, SALT LAKE CITY, UT
(801) 581-7606

Quick Facts

NPI
1619439783
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
7
Publications
20

Are you this provider?

Claim Your Profile